Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Basic & Clinical Pharmacology & Toxicology

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1742-7843.2009.00427.xPMID 19496779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term management

  2011cited by this paper
• Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice

  2009cited by this paper
• Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice.

  2009cited by this paper
• (Journal of Pharmacological Sciences, 109:496-503)Rapamycin protects against high fat diet-induced obesity in C57BL6/J mice

  2009cited by this paper
• Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.

  2008cited by this paper
• Effects of rapamycin in liver transplantation.

  2008cited by this paper
• mTOR Inhibition by Rapamycin Prevents β-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes

  2008cited by this paper
• The Role of Hypothalamic Mammalian Target of Rapamycin Complex 1 Signaling in Diet-Induced Obesity

  2008cited by this paper
• The two TORCs and Akt.

  2007cited by this paper
• Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.

  2007cited by this paper
• Role of the PI3-kinase/mTor pathway in the regulation of the stearoyl CoA desaturase (SCD1) gene expression by insulin in liver

  2007cited by this paper
• mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer.

  2007cited by this paper
• Faculty Opinions recommendation of mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.

  2007cited by this paper
• mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex

  2007cited by this paper
• Rapamycin Inhibits Growth of Premalignant and Malignant Mammary Lesions in a Mouse Model of Ductal Carcinoma In situ

  2006cited by this paper
• mTOR and cancer: reason for dancing at the crossroads?

  2006cited by this paper
• Protection against Fatty Liver but Normal Adipogenesis in Mice Lacking Adipose Differentiation-Related Protein

  2006cited by this paper
• Hypothalamic mTOR Signaling Regulates Food Intake

  2006cited by this paper
• Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation.

  2006cited by this paper
• Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?

  2006cited by this paper
• Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation

  2006cited by this paper
• Protection against Western diet–induced obesity and hepatic steatosis in liver fatty acid–binding protein knockout mice

  2006cited by this paper
• Adipophilin increases triglyceride storage in human macrophages by stimulation of biosynthesis and inhibition of β‐oxidation

  2006cited by this paper
• The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity*

  2006cited by this paper
• Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.

  2005cited by this paper
• Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells.

  2005cited by this paper
• Dietary fat content modifies liver fat in overweight nondiabetic subjects.

  2005cited by this paper
• Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.

  2005cited by this paper
• The mammalian target of rapamycin signaling network and gene regulation

  2005cited by this paper
• IN FOCUS: Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance

  2005cited by this paper
• Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in β-Cells*

  2005cited by this paper
• Role of Insulin Action and Cell Size on Protein Expression Patterns in Adipocytes*

  2004cited by this paper
• Increased oxidative stress in obesity and its impact on metabolic syndrome.

  2004cited by this paper
• Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

  2004cited by this paper
• Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase

  2004cited by this paper
• Immunosuppression and Metabolic Syndrome in Renal Transplant Recipients

  2004cited by this paper
• Adipophilin Enhances Lipid Accumulation and Prevents Lipid Efflux From THP-1 Macrophages: Potential Role in Atherogenesis

  2004cited by this paper
• Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.

  2004cited by this paper
• Protective effects of vitamin A and vitamin E succinate against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced body wasting, hepatomegaly, thymic atrophy, production of reactive oxygen species and DNA damage in C57BL/6J mice.

  2004cited by this paper
• Drug-related dyslipidemia after renal transplantation.

  2004cited by this paper
• Balancing Akt with S6K

  2004cited by this paper
• Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.

  2003cited by this paper
• Prevention of diet‐induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC)

  2003cited by this paper
• Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

  2003cited by this paper
• Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice

  2003cited by this paper
• Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.

  2002cited by this paper
• Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.

  2002cited by this paper
• Rapamycin eluting stent: the onset of a new era in interventional cardiology

  2002cited by this paper
• The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society

  2001cited by this paper
• Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade

  2001cited by this paper
• Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress.

  2001cited by this paper
• Long‐term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity

  2001cited by this paper
• Rapamycin in transplantation: a review of the evidence.

  2001cited by this paper
• Rapamycin's resurrection: a new way to target the cancer cell cycle.

  2001cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.

  2000cited by this paper
• Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes.

  2000cited by this paper
• Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice

  2000cited by this paper
• Central nervous system control of food intake

  2000cited by this paper
• Expressions of leptin and insulin-like growth factor-I are highly correlated and region-specific in adipose tissue of growing rats.

  2000cited by this paper
• Regional and gender variations in adipose tissue lipolysis in response to weight loss.

  1999cited by this paper
• Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases

  1998cited by this paper
• Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice.

  1998cited by this paper
• Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.

  1998cited by this paper
• Medical progress: Obesity.

  1997cited by this paper
• A mammalian protein targeted by G1-arresting rapamycin–receptor complex

  1994cited by this paper
• Rapamycin prevents the onset of insulin‐dependent diabetes mellitus (IDDM) in NOD mice

  1992cited by this paper
• Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man.

  1980cited by this paper
• Some aspects of pharmacokinetic and biotransformation differences in humans and mammal animals.

  1978cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Autophagy and the peroxisome proliferator-activated receptor signaling pathway: A molecular ballet in lipid metabolism and homeostasis

  2025cites this paper
• Anti-aging properties of the aminosterols of the dogfish shark

  2024cites this paper
• Intermittent rapamycin feeding recapitulates some effects of continuous treatment while maintaining lifespan extension

  2024cites this paper
• Dysregulation of pancreatic β-cell autophagy and the risk of type 2 diabetes

  2024cites this paper
• Pancreatic β-Cells, Diabetes and Autophagy

  2024cites this paper
• Evaluating the life-extending potential and safety profile of rapamycin: a Mendelian Randomization study of the mTOR pathway

  2023cites this paper
• Systematic transcriptomics analysis of calorie restriction and rapamycin unveils their synergistic interaction in prolonging cellular lifespan

  2023cites this paper
• β Cell and Autophagy: What Do We Know?

  2023cites this paper
• Cellular Senescence and Ageing.

  2023cites this paper
• Beta-cell autophagy under the scope of hypoglycemic drugs; possible mechanism as a novel therapeutic target

  2022cites this paper
• Long‐term treatment of cancer‐prone germline PTEN mutant mice with low‐dose rapamycin extends lifespan and delays tumour development

  2022cites this paper
• Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome.

  2022cites this paper
• Fasting and Fasting Mimicking Diets in Obesity and Cardiometabolic Disease Prevention and Treatment.

  2022cites this paper
• Malnutrition and immune cell subsets in children undergoing kidney transplantation

  2022cites this paper
• The use of non-model Drosophila species to study natural variation in TOR pathway signaling

  2022cites this paper
• Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways

  2022cites this paper
• Increased glycine contributes to synaptic dysfunction and early mortality in Nprl2 seizure model

  2022cites this paper
• Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice

  2021cites this paper
• The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice

  2021cites this paper
• Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice

  2021cites this paper
• FKBP51 and the molecular chaperoning of metabolism.

  2021cites this paper
• Potential Antiaging Effects of DLBS1649, a Centella asiatica Bioactive Extract

  2021cites this paper
• Anti-Cancer Effects of Zotarolimus Combined with 5-Fluorouracil Treatment in HCT-116 Colorectal Cancer-Bearing BALB/c Nude Mice

  2021cites this paper
• Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice

  2021cites this paper
• The Anti-Cancer Effects of a Zotarolimus and 5-Fluorouracil Combination Treatment on A549 Cell-Derived Tumors in BALB/c Nude Mice

  2021cites this paper
• Autophagy in Hepatic Steatosis: A Structured Review

  2021cites this paper
• The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice

  2021cites this paper
• Selenium supplementation inhibits IGF-1 signaling and confers methionine restriction-like healthspan benefits to mice

  2021cites this paper
• Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice

  2021influential citation
• Chronic everolimus treatment of high‐fat diet mice leads to a reduction in obesity but impaired glucose tolerance

  2021cites this paper
• The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin

  2021cites this paper
• Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age

  2021cites this paper
• Mirtazapine Reduces Adipocyte Hypertrophy and Increases Glucose Transporter Expression in Obese Mice

  2020cites this paper
• Breaking Bad and Breaking Good: β-Cell Autophagy Pathways in Diabetes.

  2020cites this paper
• A natural product solution to aging and aging-associated diseases.

  2020cites this paper
• Exercise Affects Blood Glucose Levels and Tissue Chromium Distribution in High-Fat Diet-Fed C57BL6 Mice

  2020cites this paper
• Is Rapamycin a Dietary Restriction Mimetic?

  2019cites this paper
• Differential effects of rapamycin on glucose metabolism in 9 inbred strains.

  2019cites this paper
• Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy.

  2019cites this paper
• Special Issue: Is vicTORy in sight? New advances in mTOR, rapalogs and aging Differential Effects of Rapamycin on Glucose Metabolism in Nine Inbred Strains

  2019cites this paper
• Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice

  2018cites this paper
• Chronic oral rapamycin decreases adiposity, hepatic triglycerides and insulin resistance in male mice fed a diet high in sucrose and saturated fat

  2018cites this paper
• Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J‐Leprdb mice

  2018cites this paper
• Rapamycin increases oxidative metabolism and enhances metabolic flexibility in human cardiac fibroblasts

  2018cites this paper
• β-Cell Autophagy in Diabetes Pathogenesis.

  2018cites this paper
• A small molecule inhibitor of Rheb selectively targets mTORC1 signaling

  2018cites this paper
• Cysteine‐rich protein 61 regulates adipocyte differentiation from mesenchymal stem cells through mammalian target of rapamycin complex 1 and canonical Wnt signaling

  2018cites this paper
• Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing

  2017cites this paper
• Rapamycin‐ameliorated diabetic symptoms involved in increasing adiponectin expression in diabetic mice on a high‐fat diet

  2017cites this paper
• Nutrition, metabolism, and targeting aging in nonhuman primates.

  2017cites this paper
• Towards natural mimetics of metformin and rapamycin

  2017cites this paper
• Effects of Rapamycin on Clinical Manifestations and Blood Lipid Parameters in Different Preeclampsia-like Mouse Models

  2017cites this paper
• Molecular mechanisms underlying metabolic syndrome: the expanding role of the adipocyte

  2017cites this paper
• Isoproterenol exacerbates hyperglycemia and modulates chromium distribution in mice fed with a high fat diet.

  2017cites this paper
• Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis

  2017cites this paper
• Experimental Models for Aging and their Potential for Novel Drug Discovery

  2017cites this paper
• Rapamycin reduces motivated responding for cocaine and alters GluA1 expression in the ventral but not dorsal striatum.

  2016cites this paper
• Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes

  2016influential citation
• Rapamycin Versus Intermittent Feeding: Dissociable Effects on Physiological and Behavioral Outcomes When Initiated Early and Late in Life.

  2016cites this paper
• Rapamycin increases grip strength and attenuates age-related decline in maximal running distance in old low capacity runner rats

  2016cites this paper
• Manipulation of health span and function by dietary caloric restriction mimetics

  2016cites this paper
• Timcodar (VX-853) Is a Non-FKBP12 Binding Macrolide Derivative That Inhibits PPARγ and Suppresses Adipogenesis

  2016cites this paper
• Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice

  2016cites this paper
• The Impact Of Folate Restriction On Cancer And Aging: A Mechanistic Analysis

  2016cites this paper
• Regulation of macroautophagy by nutrients and metabolites

  2016cites this paper
• Chronic mTOR Inhibition by Rapamycin and Diabetes

  2016cites this paper
• Staying young at heart: autophagy and adaptation to cardiac aging.

  2016cites this paper
• The Gut Microflora and its Metabolites Regulate the Molecular Crosstalk between Diabetes and Neurodegeneration

  2015cites this paper
• Rapamycin impairs HPD‐induced beneficial effects on glucose homeostasis

  2015cites this paper
• mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging

  2015cites this paper
• mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems.

  2015cites this paper
• The Roles of mTOR Complexes in Lipid Metabolism.

  2015cites this paper
• Calorie restriction mimetics: can you have your cake and eat it, too?

  2015cites this paper
• Resveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice

  2015cites this paper
• Essential role for autophagy in life span extension.

  2015cites this paper
• Nutrition, Exercise and Epigenetics: Ageing Interventions

  2015cites this paper
• Calorie Restriction Mimetics: Progress and Potential

  2015cites this paper
• The two faces of miR-29

  2015cites this paper
• Regulation of Cardiac Expression of the Diabetic Marker MicroRNA miR-29

  2014cites this paper
• Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium

  2014cites this paper
• Koschei the immortal and anti-aging drugs

  2014cites this paper
• Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model.

  2014cites this paper
• Rapamycin: one drug, many effects.

  2014cites this paper
• Influence of mTOR in energy and metabolic homeostasis.

  2014cites this paper
• Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo

  2014cites this paper
• Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ

  2014cites this paper
• Chronic rapamycin treatment causes diabetes in male mice.

  2014cites this paper
• Beneficial Metabolic Effects of Rapamycin Are Associated with Enhanced Regulatory Cells in Diet-Induced Obese Mice

  2014cites this paper
• Hypothalamic mTOR: the rookie energy sensor.

  2014cites this paper
• Rapamycin-induced metabolic defects are reversible in both lean and obese mice

  2014influential citation
• Comparison of rapamycin schedules in mice on high-fat diet

  2014cites this paper
• Inhibition of mTOR kinase via rapamycin blocks persistent predator stress-induced hyperarousal.

  2013cites this paper
• Duration of rapamycin treatment has differential effects on metabolism in mice.

  2013cites this paper
• Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy.

  2013cites this paper
• Post-prandial regulation of hepatic glucokinase and lipogenesis requires the activation of TORC1 signalling in rainbow trout (Oncorhynchus mykiss)

  2013cites this paper
• A molecular rheostat at the interface of cancer and diabetes.

  2013cites this paper
• TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists

  2013cites this paper
• Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model.

  2013cites this paper
• Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet

  2013cites this paper
• Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia.

  2012cites this paper